The realistic dilemma and institutional optimization of the accessibility of patented medicines——a concurrent review on the operation of Medicines Patent Pool
HUANGFU Jie-qiong
ZHONG Yan
Abstract：To address the issue of drug accessibility in low-and middle-income countries,the Medicines Patent Pool(MPP)was built by the International Medicines Purchasing Agency.However,China has not been included in the scope of licensed sales.This paper conducts a study on the operation mechanism of MPP and the its impact on China,and explores the prospects and specific ways in which China can cooperate with MPP,which will help provide domestic pharmaceutical companies with more possibilities for international competition and international cooperation,expand the market share and utilization rate of China's drugs in low-and middle-income countries,and provide a reference for China to develop ways to improve its international influence.
Keywords：medicines patent poolmedicinepatentaccessibility
Publication Date：2024-05-15
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：4( 864-867 )